January 22nd, 2022

64x Bio's iterative solutions to vector manufacturing pain points

January 19th, 2022

Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech

 

January 19th, 2022

A George Church spinout fighting the viral vector bottleneck in cell and gene therapy lands $55M

January 19th, 2022

Here is the 10-slide deck a new biotech company addressing a critical gene- therapy bottleneck used to raise $55 million in just a few months

January 19th, 2022

64x Bio Raises $55M To Advance Gene Therapy Platform

January 19th, 2022

64x Bio Lands $55 Million for Gene-Therapy Tech

January 19th, 2022

64x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturing

November 20th, 2020

George Church backs a startup solution to the massive gene therapy manufacturing bottleneck

November 16th, 2020

64x Bio emerges from stealth to drive an evolution in cell and gene therapy manufacturing

December 27, 2019

One year, 1 lab, 16 spinouts

December 8, 2019

A Harvard geneticist's goal: to protect humans from viruses, genetic diseases, and aging

December 3, 2019

The synthetic biology revolution is here

November 18, 2019

SynBioBeta: synthetic biology the next big thing after computers

November 7, 2019

Harvard scientist’s breakthrough could make humans resistant to all viruses

February 26, 2019

What’s in the water at the George Church lab?

 

August 24, 2018

The female-founded startups at Y Combinator Demo Day 2

 

August 22, 2018

At Y Combinator, startups manage molecules rather than code

August 22, 2018

The top 10 startups from Y Combinator's Demo Day S18 day 2

August 21, 2018

All 59 startups that launched today at Y Combinator's S18 Demo Day 2